232 related articles for article (PubMed ID: 16301995)
1. Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1.
Britschgi C; Rizzi M; Grob TJ; Tschan MP; Hügli B; Reddy VA; Andres AC; Torbett BE; Tobler A; Fey MF
Oncogene; 2006 Mar; 25(14):2030-9. PubMed ID: 16301995
[TBL] [Abstract][Full Text] [Related]
2. The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1.
Jenal M; Trinh E; Britschgi C; Britschgi A; Roh V; Vorburger SA; Tobler A; Leprince D; Fey MF; Helin K; Tschan MP
Mol Cancer Res; 2009 Jun; 7(6):916-22. PubMed ID: 19491197
[TBL] [Abstract][Full Text] [Related]
3. The UV responsive elements in the human mimecan promoter: a functional characterization.
Tasheva ES; Conrad GW
Mol Vis; 2003 Jan; 9():1-9. PubMed ID: 12533723
[TBL] [Abstract][Full Text] [Related]
4. [Chromosome arm 17p13.3: could HIC1 be the one ?].
Chopin V; Leprince D
Med Sci (Paris); 2006 Jan; 22(1):54-61. PubMed ID: 16386221
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses.
Chen WY; Wang DH; Yen RC; Luo J; Gu W; Baylin SB
Cell; 2005 Nov; 123(3):437-48. PubMed ID: 16269335
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the Oct-1 regulatory element of the gadd45 promoter in the p53-independent response to ultraviolet irradiation.
Takahashi S; Saito S; Ohtani N; Sakai T
Cancer Res; 2001 Feb; 61(3):1187-95. PubMed ID: 11221850
[TBL] [Abstract][Full Text] [Related]
7. Characterization of HRG22, a human homologue of the putative tumor suppressor gene HIC1.
Deltour S; Pinte S; Guérardel C; Leprince D
Biochem Biophys Res Commun; 2001 Sep; 287(2):427-34. PubMed ID: 11554746
[TBL] [Abstract][Full Text] [Related]
8. A L225A substitution in the human tumour suppressor HIC1 abolishes its interaction with the corepressor CtBP.
Stankovic-Valentin N; Verger A; Deltour-Balerdi S; Quinlan KG; Crossley M; Leprince D
FEBS J; 2006 Jul; 273(13):2879-90. PubMed ID: 16762039
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis.
Chen W; Cooper TK; Zahnow CA; Overholtzer M; Zhao Z; Ladanyi M; Karp JE; Gokgoz N; Wunder JS; Andrulis IL; Levine AJ; Mankowski JL; Baylin SB
Cancer Cell; 2004 Oct; 6(4):387-98. PubMed ID: 15488761
[TBL] [Abstract][Full Text] [Related]
10. Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors.
Chen WY; Zeng X; Carter MG; Morrell CN; Chiu Yen RW; Esteller M; Watkins DN; Herman JG; Mankowski JL; Baylin SB
Nat Genet; 2003 Feb; 33(2):197-202. PubMed ID: 12539045
[TBL] [Abstract][Full Text] [Related]
11. Identification of a second G-C-rich promoter conserved in the human, murine and rat tumor suppressor genes HIC1.
Pinte S; Guérardel C; Deltour-Balerdi S; Godwin AK; Leprince D
Oncogene; 2004 May; 23(22):4023-31. PubMed ID: 15007385
[TBL] [Abstract][Full Text] [Related]
12. HIC1 tumour suppressor gene is suppressed in acute myeloid leukaemia and induced during granulocytic differentiation.
Britschgi C; Jenal M; Rizzi M; Mueller BU; Torbett BE; Andres AC; Tobler A; Fey MF; Tschan MP
Br J Haematol; 2008 Apr; 141(2):179-87. PubMed ID: 18318772
[TBL] [Abstract][Full Text] [Related]
13. The critical role of the PE21 element in oncostatin M-mediated transcriptional repression of the p53 tumor suppressor gene in breast cancer cells.
Li C; Ahlborn TE; Tokita K; Boxer LM; Noda A; Liu J
Oncogene; 2001 Dec; 20(57):8193-202. PubMed ID: 11781835
[TBL] [Abstract][Full Text] [Related]
14. Aberrant methylation of the HIC1 promoter is a frequent event in specific pediatric neoplasms.
Rathi A; Virmani AK; Harada K; Timmons CF; Miyajima K; Hay RJ; Mastrangelo D; Maitra A; Tomlinson GE; Gazdar AF
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3674-8. PubMed ID: 14506157
[TBL] [Abstract][Full Text] [Related]
15. Functional promoter upstream p53 regulatory sequence of IGFBP3 that is silenced by tumor specific methylation.
Hanafusa T; Shinji T; Shiraha H; Nouso K; Iwasaki Y; Yumoto E; Ono T; Koide N
BMC Cancer; 2005 Jan; 5():9. PubMed ID: 15661074
[TBL] [Abstract][Full Text] [Related]
16. DNA damage signalling recruits RREB-1 to the p53 tumour suppressor promoter.
Liu H; Hew HC; Lu ZG; Yamaguchi T; Miki Y; Yoshida K
Biochem J; 2009 Aug; 422(3):543-51. PubMed ID: 19558368
[TBL] [Abstract][Full Text] [Related]
17. A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network.
Menendez D; Krysiak O; Inga A; Krysiak B; Resnick MA; Schönfelder G
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1406-11. PubMed ID: 16432214
[TBL] [Abstract][Full Text] [Related]
18. Generation of two modified mouse alleles of the Hic1 tumor suppressor gene.
Pospichalova V; Tureckova J; Fafilek B; Vojtechova M; Krausova M; Lukas J; Sloncova E; Takacova S; Divoky V; Leprince D; Plachy J; Korinek V
Genesis; 2011 Mar; 49(3):142-51. PubMed ID: 21309068
[TBL] [Abstract][Full Text] [Related]
19. Identification and functional characterization of a novel unspliced transcript variant of HIC-1 in human cancer cells exposed to adverse growth conditions.
Mondal AM; Chinnadurai S; Datta K; Chauhan SS; Sinha S; Chattopadhyay P
Cancer Res; 2006 Nov; 66(21):10466-77. PubMed ID: 17079468
[TBL] [Abstract][Full Text] [Related]
20. KLF4 positively regulates human ghrelin expression.
Lee HJ; Kang YM; Moon CS; Joe MK; Lim JH; Suh YH; Song J; Jung MH
Biochem J; 2009 May; 420(3):403-11. PubMed ID: 19327128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
